Search for: "MYLAN PHARMACEUTICALS INC"
Results 1 - 20
of 496
Sort by Relevance
|
Sort by Date
9 Apr 2024, 2:56 pm
Proc. 97-35, and cases like RJR Nabisco, Inc. v. [read post]
1 Apr 2024, 10:58 am
Janssen Pharms., Inc. v. [read post]
13 Mar 2024, 7:24 pm
., Inc. v. [read post]
9 Feb 2024, 11:08 am
” Similarly, as show in the Mylan Laby’s, Inc. v. [read post]
14 Jan 2024, 9:29 pm
Mylan Pharmaceuticals Inc. [read post]
2 Jan 2024, 8:45 pm
Mylan Pharmaceuticals Inc. [read post]
18 Dec 2023, 9:07 pm
Mylan Pharmaceuticals Inc. [read post]
13 Dec 2023, 8:25 pm
Mylan Pharmaceuticals Inc. [read post]
7 Dec 2023, 9:59 pm
Mylan Pharmaceuticals Inc., with the Court vacating and remanding the District Court's claim construction for failure to consider extrinsic evidence. [read post]
6 Nov 2023, 1:15 pm
Mylan Pharmaceuticals Inc. vacating an infringement judgment against Mylan in the Northern District of West Virginia. [read post]
6 Nov 2023, 1:15 pm
Mylan Pharmaceuticals Inc. vacating an infringement judgment against Mylan in the Northern District of West Virginia. [read post]
6 Nov 2023, 8:35 am
Mylan Pharmaceuticals Inc., No. 2022-1889 (Fed. [read post]
2 Aug 2023, 11:05 am
Sanofi argued on appeal that the Board erroneously agreed with Mylan’s argument that de Gennes constituted analogous art because Mylan incorrectly compared the de Gennes reference to another prior art reference, and not the ’614 patent. [read post]
25 May 2023, 6:00 am
Mylan Pharmaceuticals Inc., No. 2021-1981, 2023 U.S. [read post]
5 Apr 2023, 5:18 am
The CA upheld this in Neurim v Generics UK Limited (t/a Mylan) [2022] EWCA Civ 370. [read post]
23 Jan 2023, 10:40 am
TRIAD Rx, Inc. will pay $166,547. [read post]
14 Nov 2022, 12:15 am
Last week, the Securities and Exchange Commission announced that it had filed a complaint against the Chief Information Officer of pharmaceutical company Viatris Inc. [read post]
10 Nov 2022, 1:25 pm
The Securities and Exchange Commission today announced insider trading charges against Ramkumar Rayapureddy, Chief Information Officer of pharmaceutical company Viatris Inc., which was formerly known as Mylan N.V. [read post]
5 Oct 2022, 8:12 pm
Patent No. 7,326,708 were either anticipated or rendered obvious by the asserted prior art, in Mylan Pharmaceuticals Inc. v. [read post]
3 Oct 2022, 8:27 am
Mylan Pharmaceuticals Inc., No. 21-1567 [read post]
